FindTrial
Sign In

A clinical trial to study the effects of Jawarish Bisbasa and Jawarish Falafali in the patients of subclinical hypothyroidism.

Clinical effect of jawarish bisbasa versus jawarish falafali in patients with subclinical hypothyroidism: A randomized comparative parallel clinical trial. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104059
Enrollment
60
Registered
2026-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Jawarish Bisbasa: Jawarish Bisbasa 5 g orally twice a day after meal with lukewarm water for 90 days. Control Intervention1: Jawarish Falafali: Jawarish Falafali 5 g orally twice a day

Sponsors

Dr Shaikh Sofia Tarannum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed subjects of subclinical hypothyroidism. Subjects having TSH level more than 5.5 micro IU/ ml and less than 15 micro IU/ml.

Exclusion criteria

Exclusion criteria: Subjects on iodine containing vitamins or minerals. Subjects suffering with any chronic medical illness like DM, HTN, IHD, Heart Failure, CKD, RA etc. Subjects with other than Subclinical Hypothyroidism, Myxoedema, Hashimoto s thyroiditis, Riedel s thyroiditis, Hyperthyroidism etc. Subjects who fail to give consent.

Design outcomes

Secondary

MeasureTime frame
NilTimepoint: Nil—

Primary

MeasureTime frame
Reduction in subjective parameters such as weight gain, cold intolerance, lethargy and constipation. Reduction in TSH and complete thyroid profile before and after trial.Timepoint: 90 days—

Countries

India

Contacts

Public ContactDr Md Razi Ahmad

Government Tibbi College and Hospital Kadam Kuan Patna

drmdnajibur.rahman@gmail.com7004484257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026